Glycemic control [using HbA1c (%) levels] after three months of treatment with repaglinide versus metformin monotherapy; as initial treatment in patients with newly diagnosed type 2 diabetes mellitus naive to oral hypoglycemic agents

Authors
Category Primary study
Registry of TrialsSri Lanka Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: 4f4b501b8b1d3a7ac2bea17fd2e680e49cdbe057
First added on: May 10, 2025